Sichuan Goldstone Asia Pharmaceutical Inc. (SHE:300434)

SHE:300434 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	4,226	3,314	4,443	5,468	4,363	3,065
Market Cap Growth	22.04%	-25.41%	-18.74%	25.32%	42.33%	-0.26%
Enterprise Value	3,977	2,833	3,779	5,197	4,148	2,746
Last Close Price	10.52	8.19	10.82	13.32	10.63	7.47
PE Ratio	31.46	36.12	35.21	24.99	65.63	-
PS Ratio	4.01	3.01	3.68	4.40	4.14	3.94
PB Ratio	1.66	1.34	1.83	2.37	2.02	1.49
P/TBV Ratio	1.91	1.55	2.15	2.95	2.65	1.83
P/FCF Ratio	31.63	38.89	52.25	20.33	85.50	31.31
P/OCF Ratio	17.73	20.96	29.40	16.93	31.99	23.05
EV/Sales Ratio	3.77	2.57	3.13	4.18	3.94	3.53
EV/EBITDA Ratio	16.21	12.30	11.30	13.98	20.49	35.01
EV/EBIT Ratio	29.32	22.07	15.71	18.51	35.93	-
EV/FCF Ratio	29.76	33.24	44.43	19.33	81.28	28.04
Debt / Equity Ratio	0.05	0.03	0.05	0.00	0	0.01
Debt / EBITDA Ratio	0.52	0.34	0.34	0.03	0.00	0.13
Debt / FCF Ratio	0.95	0.91	1.35	0.04	0.02	0.10
Asset Turnover	0.36	0.36	0.39	0.43	0.40	0.27
Inventory Turnover	2.15	2.11	2.15	2.32	2.26	2.13
Quick Ratio	1.59	1.70	1.83	1.50	1.28	1.94
Current Ratio	2.30	2.18	2.28	1.86	1.82	2.60
Return on Equity (ROE)	5.13%	3.62%	5.11%	9.54%	3.13%	-28.33%
Return on Assets (ROA)	2.89%	2.61%	4.88%	6.02%	2.74%	-0.17%
Return on Invested Capital (ROIC)	5.14%	4.69%	8.97%	11.18%	4.72%	-0.39%
Return on Capital Employed (ROCE)	5.20%	5.00%	9.60%	11.80%	5.10%	-0.40%
Earnings Yield	3.09%	2.77%	2.84%	4.00%	1.52%	-22.43%
FCF Yield	3.16%	2.57%	1.91%	4.92%	1.17%	3.19%
Dividend Yield	0.66%	0.84%	1.02%	-	-	-
Payout Ratio	22.15%	49.27%	0.59%	0.05%	0.49%	-
Buyback Yield / Dilution	7.40%	2.00%	-0.48%	-3.60%	2.75%	-0.26%
Total Shareholder Return	8.05%	2.84%	0.54%	-3.60%	2.75%	-0.26%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.